APPLICATION
NDA206927
TYPE
NDA
ORIGINAL APPROVAL
2019-10-04
LATEST ACTION
2022-02-28
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
BORTEZOMIBDiscontinued
BORTEZOMIB 3.5MG/VIAL · POWDER · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.